1-11 of 11
Scott Dunkley
Close
Sort by
Journal Articles

Safety and Efficacy of R-CEEP (Rituximab, Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) in Elderly or Unfit Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Retrospective Single-Centre Experience

James Yeung, MBBS, Ashlea Campbell, BSc MBBS FRACP FRCPA, Christian E Bryant, MBBS PhDFRACP FRCPA, Liane Khoo, MBBS PhDFRACP FRCPA, Scott Dunkley, MBBS FRACP FRCPA, Harry J Iland, MBBS FRACP FRCPA MHGSA, Stephen R Larsen, MBBS PhDFRACP FRCPA, Susan Moreton, MBBS FRACP FRCPA, Douglas E Joshua, BSc(Hons) MBBS DPhil FRACP FRCPA, Vinay Vanguru, MBBS FRACP FRCPA, Derek A McCulloch, BSc MBBChir PhDFRACP FRCPA, Danny Hsu, MBBS FRACP FRCPA, John Gibson, MBBS PhDFRACP FRCPA, P. Joy Ho, MBBS DPhil FRACP FRCPA, Christina Brown, MBBS PhDFRACP FRCPA
Journal: Blood
Blood (2019) 134 (Supplement_1): 2911.
https://doi.org/10.1182/blood-2019-131589
Published: 2019
Journal Articles

First Report on the Safety and Efficacy of a Long-Acting Recombinant FVIII (turoctocog alfa pegol, N8-GP) during Major Surgery in Patients with Severe Hemophilia a

Kingsley Hampton, Pratima Chowdary, Scott Dunkley, Silke Ehrenforth, MD PhD, Lotte Jacobsen, Anne T. Neff, MD, Elena Santagostino, MD PhD, Jameela Sathar, Hideyuki Takedani, Clifford M. Takemoto, MD, Claude Négrier
Journal: Blood
Blood (2015) 126 (23): 2283.
https://doi.org/10.1182/blood.V126.23.2283.2283
Published: 2015
Journal Articles

Coagulopathy Is a Strong Independent Predictor Of In-Hospital Mortality Following Massive Transfusion: Initial Results From The Australian and New Zealand Massive Transfusion Registry (ANZ-MTR)

Amanda J Zatta, BSc (Hons), PhD, Zoe K McQuilten, MBBS, Nick Andrianopoulos, MBBS, MBiostat, David J Roxby, MBBS, Naomi J Aoki, BSc, MSc, Krishna Badami, MBBS, Larry McNicol, MBBS, Ken Davis, BSc (Hons), Scott Dunkley, MBBS, Catherine Hurn, MBBS, Louise E Phillips, BSc(Hons), MPH, PhD, James P Isbister, MBBS, Peter A Cameron, MBBS, PhD, Erica M Wood, MBBS
Journal: Blood
Blood (2013) 122 (21): 2402.
https://doi.org/10.1182/blood.V122.21.2402.2402
Published: 2013
Journal Articles

Recombinant Activated Factor VII for Bleeding In the Setting of Malignancy or Hematopoietic Stem Cell Transplantation: The Australian and New Zealand Experience, 2000–2009,

Mark N Polizzotto, MBBS, BMedSc, Amanda J Zatta, BSc (Hons), PhD, Merrole F Cole-Sinclair, MBBS, BSc (Hons), Erica M Wood, MBBS, Zoe K McQuilten, MBBS, Scott Dunkley, MBBS FRACP FRCPA, Peter Cameron, MBBS, PhD, Louise E Phillips, BSc (Hons), MPH, PhD
Journal: Blood
Blood (2011) 118 (21): 3311.
https://doi.org/10.1182/blood.V118.21.3311.3311
Published: 2011
Journal Articles

Safety and Efficacy of CEEP (Cyclophosphamide, Epirubicin, Etoposide, Prednisolone) with or without Rituximab in Elderly Patients (>70) with Diffuse Large B-Cell Lymphoma (DLBL): A Retrospective Single Center Experience

Danny Hsu, MBBS FRACP FRCPA, Ibrahim Tohidi-Esfahani, MBBS, Christina Brown, MBBS PhD FRACP FRCPA, Scott Dunkley, MBBS FRACP FRCPA, Stephen Robert Larsen, MBBS FRACP FRCPA PhD, Phoebe Joy Ho, MBBS FRCPA FRACP DPhil, Harry Iland, MBBS FRACP FRCPA MHGSA, John Gibson, MBBS FRACP FRCPA DPhil, Douglas E. Joshua, MBBS DPhil FRACP FRCPA AM
Journal: Blood
Blood (2011) 118 (21): 4957.
https://doi.org/10.1182/blood.V118.21.4957.4957
Published: 2011
Journal Articles

Ten Years and Over 3600 Cases of Recombinant Activated Factor VII Use: What Does the Haemostasis Registry Data Tell Us?

Louise E Phillips, BSc, (hons), MPH, PhD, Amanda J Zatta, BSc, (Hons), PhD, James Isbister, MD, Scott Dunkley, MD, John McNeil, MD, PhD, Peter Cameron, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3352.
https://doi.org/10.1182/blood.V116.21.3352.3352
Published: 2010
Journal Articles

Adherence to Transfusion Protocols and the Use of Recombinant Activated Factor VII.

Louise E Phillips, BSc, (Hons), PhD, Cameron Willis, PhD, Amanda Zatta, PhD, Scott Dunkley, BMed(hons), FRACP, FRCPA, Peter Cameron, MD, MBBS, FACEM, Hatem H. Salem, MD, FRACP, FRCPA, James Isbister, MB, BS, BSc(MED), FRACP, FRCPA
Journal: Blood
Blood (2009) 114 (22): 4192.
https://doi.org/10.1182/blood.V114.22.4192.4192
Published: 2009
Journal Articles

Maintaining Imatinib ≥600 Mg Daily in the First 12 Months of Chronic Phase CML Treatment Is Associated with Superior Event-Free Survival at 5 Years.

Michael P Osborn, Susan Branford, PhD, Deborah L White, PhD, John F Seymour, PhD, Ruth Columbus, Kerry Taylor, Christopher Arthur, Anthony Schwarer, Julian Cooney, MD, Michael F Leahy, Philip Rowlings, John Catalano, MD, Mark S Hertzberg, MD, PhD, Robin Filshie, PhD, Anthony K Mills, Keith Fay, Simon Durrant, Henry Januszewicz, David Joske, MD, Craig Underhill, Scott Dunkley, PhD, Andrew Grigg, Timothy P Hughes, MD
Journal: Blood
Blood (2009) 114 (22): 1125.
https://doi.org/10.1182/blood.V114.22.1125.1125
Published: 2009
Journal Articles

Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy

Clinical Trials & Observations
Timothy P. Hughes, Susan Branford, Deborah L. White, John Reynolds, Rachel Koelmeyer, John F. Seymour, Kerry Taylor, Chris Arthur, Anthony Schwarer, James Morton, Julian Cooney, Michael F. Leahy, Philip Rowlings, John Catalano, Mark Hertzberg, Robin Filshie, Anthony K. Mills, Keith Fay, Simon Durrant, Henry Januszewicz, David Joske, Craig Underhill, Scott Dunkley, Kevin Lynch, Andrew Grigg
Journal: Blood
Blood (2008) 112 (10): 3965–3973.
https://doi.org/10.1182/blood-2008-06-161737
Published: 2008
Includes: Supplemental data
Journal Articles

The Use of Recombinant Activated Factor VII in Australia and New Zealand.

Scott Dunkley, Peter A. Cameron, MBBS FACEM MD, Louise E. Phillips, BSc (Hons) PhD, James Isbister
Journal: Blood
Blood (2006) 108 (11): 4025.
https://doi.org/10.1182/blood.V108.11.4025.4025
Published: 2006
Journal Articles

Thrombophilia as a common predisposing factor in pseudotumor cerebri

Scott Dunkley, Ian Johnston
Journal: Blood
Blood (2004) 103 (5): 1972–1973.
https://doi.org/10.1182/blood-2003-09-3017
Published: 2004